Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 545 entries
View as:

Multifactorial Intervention on Frailty in Vulnerable Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT02554994 Org: User:
Start: 08/31/15 End: 01/31/17 Due: 01/31/18

Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum

Phase: N/A Priority: Normal
NCT ID: NCT01426126 Org: User:
Start: 12/31/07 End: 08/31/11 Due: 08/31/12

Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT01068990 Org: User:
Start: 03/31/10 End: 02/28/28 Due: 02/28/29

Pivotal Study to Evaluate the Efficacy and Safety of Injection With LASBEAU Strong in Correction of Nasolabial Folds

Phase: N/A Priority: Normal
NCT ID: NCT06310863 Org: User:
Start: 10/07/19 End: 11/24/20 Due: 11/24/21

Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)

Phase: N/A Priority: Normal
NCT ID: NCT02081729 Org: User:
Start: 03/31/14 End: 08/31/15 Due: 08/31/16

Effect of Remimazolam and Propofol on Hemodynamic Stability in Prone Position

Phase: N/A Priority: Normal
NCT ID: NCT05644483 Org: User:
Start: 03/29/22 End: 01/25/23 Due: 01/25/24

Comparison in Frequency of Hypotension Between Remimazolam and Propofol in Hip Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05651399 Org: User:
Start: 12/26/22 End: 06/14/23 Due: 06/14/24

Abbreviated R-CHOP in Completely Excised Stage I or II DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT01279902 Org: User:
Start: 08/31/10 End: 01/31/17 Due: 01/31/18

Clinical Trial to Compare the Pharmacokinetics and Pharmacodynamics After Oral Administration of Glucophage and HL-018

Phase: N/A Priority: Normal
NCT ID: NCT01232036 Org: User:
Start: 05/31/10 End: 10/31/10 Due: 10/31/11

Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01679483 Org: User:
Start: 09/30/12 End: 11/30/15 Due: 11/30/16

Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT04877678 Org: User:
Start: 10/01/21 End: 10/31/22 Due: 10/31/23

Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01461746 Org: User:
Start: 10/31/11 End: 12/31/17 Due: 12/31/18

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Phase: N/A Priority: Normal
NCT ID: NCT06819566 Org: User:
Start: 02/15/25 End: 03/31/29 Due: 03/31/30

Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

Phase: N/A Priority: Normal
NCT ID: NCT01547143 Org: User:
Start: 03/31/12 End: 05/31/16 Due: 05/31/17

The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients

Phase: N/A Priority: Normal
NCT ID: NCT01869205 Org: User:
Start: 03/31/13 End: 04/30/17 Due: 04/30/18

Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01186081 Org: User:
Start: 03/31/04 End: 08/31/09 Due: 08/31/10

ED90 of Remimazolam Loading Dose for Sedation in Patients Under Monitored Anesthetic Care

Phase: N/A Priority: Normal
NCT ID: NCT05340335 Org: User:
Start: 04/18/22 End: 05/02/22 Due: 05/02/23

[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib

Phase: N/A Priority: Normal
NCT ID: NCT02175095 Org: User:
Start: 07/18/14 End: 04/30/19 Due: 04/30/20

S-1 and Photodynamic Therapy in Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00869635 Org: User:
Start: 02/28/09 End: 08/31/13 Due: 08/31/14

Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04308174 Org: User:
Start: 05/20/20 End: 12/30/25 Due: 12/30/26

Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients

Phase: N/A Priority: Normal
NCT ID: NCT00468078 Org: User:
Start: 11/30/06 End: 10/31/07 Due: 10/31/08

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT00336583 Org: User:
Start: 06/30/06 End: 01/31/08 Due: 01/31/09

Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01375972 Org: User:
Start: 03/31/08 End: 08/31/11 Due: 08/31/12

IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis

Phase: N/A Priority: Normal
NCT ID: NCT02175134 Org: User:
Start: 07/31/14 End: 06/30/18 Due: 06/30/19

Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03435107 Org: User:
Start: 04/12/18 End: 04/26/23 Due: 04/26/24